文献速递瓣膜外科主动脉外科

年龄对无支架主动脉瓣耐久性的影响

Influence of Age on Longevity of a Stentless Aortic Valve.
PubMed 文献 · Ann Thorac Surg · 2019-12-23

研究回顾1992至2015年1947例无支架生物瓣行主动脉瓣/根部置换患者,按年龄分组分析再手术累积发生率。年轻组(<40岁、40-59岁)再手术风险显著高于老年组(60-74岁、≥75岁),<40岁 vs ≥75岁风险比达12。结论认为无支架瓣耐久性可接受,但<60岁患者应审慎考虑。

要点

  • 年轻患者(<60岁)因结构瓣毁损再手术风险显著高于老年患者
  • <40岁患者再手术风险比≥75岁高12倍
  • 无支架瓣整体耐久性满意,但<60岁需审慎选择

核心结论

  • 无支架主动脉瓣作为主动脉瓣/根部置换的管道耐久性满意,但<60岁患者因结构瓣毁损再手术发生率增加,应审慎考虑。

研究设计与样本

  • 回顾性队列研究,1992至2015年1947例患者行无支架生物瓣主动脉瓣/根部置换,中位瓣膜尺寸26 mm。
  • 年龄分组:<40岁105例,40-59岁528例,60-74岁860例,≥75岁454例。
  • 数据来源包括病历回顾、问卷调查和国家死亡指数。

主要发现

  • 30天死亡率为2.6%。
  • 随访期间807例(41%)在再手术前死亡,993例(51%)存活且未因瓣膜毁损再手术,113例(5.8%)因结构瓣毁损再手术。
  • 调整非结构瓣毁损死因作为竞争风险后,年轻组(<40、40-59)与老年组(60-74、≥75)再手术累积发生率差异显著(P < .0001),年轻组内(<40 vs 40-59)和老年组内(60-74 vs ≥75)无显著差异。
  • 再手术显著风险比:<40 vs ≥75为12,<40 vs 60-74为4,40-59 vs 60-74为3,40-59 vs ≥75为9(P ≤ .01)。
  • 全队列10年和15年生存率分别为53%和29%。

临床怎么用

  • 对<60岁偏好生物瓣的患者,选择无支架瓣时应充分告知结构瓣毁损再手术风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The longevity of a stentless valve in a younger population (20-60 years old) is unknown. METHODS: From 1992 to 2015, 1947 patients underwent aortic valve/root replacement for aortic stenosis, insufficiency, root aneurysm, or aortic dissection with stentless bioprostheses (median size, 26 mm). At operation 105 patients were <40 years old, 528 were 40 to 59, 860 were 60 to 74, and 454 were ≥75 years. The data were obtained through chart review, administered surveys, and the National Death Index. RESULTS: The 30-day mortality rate was 2.6%. During follow-up 807 patients (41%) died before reoperation, 993 (51%) were alive without reoperations because of deterioration, and 113 patients (5.8%) underwent reoperation for structural valve deterioration. After adjusting death and reoperation for non-structural valve deterioration causes as competing risks, the cumulative incidence of reoperation was significantly different between the younger groups (<40, 40-59) and the older groups (60-74, ≥75; P < .0001) but not inside the younger (<40 vs 40-59) or older (60-74 vs ≥75) group. The significant hazard ratio of reoperation for <40 versus ≥75 years of age was 12, <40 versus 60 to 74 was 4, 40 to 59 versus 60 to 74 was 3, and 40 to 59 versus ≥75 was 9 (P ≤ .01). The 10- and 15-year survival in the entire cohort was 53% and 29%, respectively. CONCLUSIONS: The stentless aortic valve provides satisfactory durability as a conduit for aortic valve/root replacement for patients who prefer a bioprosthesis. However it should be judiciously considered for patients younger than 60 years because of an increased incidence of reoperation for structural valve deterioration.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Yang B, Malik A, Farhat L, et al. Influence of Age on Longevity of a Stentless Aortic Valve. Ann Thorac Surg. 2019. PMID: 31877296. doi:10.1016/j.athoracsur.2019.10.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。